References
Guo, D. et al. Nat. Genet. 36, 837–841 (2004).
Bohren, K.M., Nadkarni, V., Song, J.H., Gabbay, K.H. & Owerbach, D. J. Biol. Chem. 279, 27233–27238 (2004).
The International HapMap Consortium. Nature 426, 789–796 (2003).
Horvath, S., Xu, X. & Laird, N.M. Eur. J. Hum. Genet. 9, 301–306 (2001).
Newhook, L.A. et al. Diabetes Care 27, 885–888 (2004).
Author information
Authors and Affiliations
Corresponding author
Supplementary information
Rights and permissions
About this article
Cite this article
Qu, H., Bharaj, B., Liu, XQ. et al. Assessing the validity of the association between the SUMO4 M55V variant and risk of type 1 diabetes. Nat Genet 37, 111–112 (2005). https://doi.org/10.1038/ng0205-111
Issue Date:
DOI: https://doi.org/10.1038/ng0205-111
- Springer Nature America, Inc.
This article is cited by
-
Small ubiquitin-like modifier-4 Met55Val polymorphism is associated with glycemic control of Type 2 diabetes mellitus in Taiwan
Journal of Endocrinological Investigation (2010)
-
Polymorphisms in the ADRB2 gene and Graves disease: a case-control study and a meta-analysis of available evidence
BMC Medical Genetics (2009)
-
Analyses of multiple single-nucleotide polymorphisms in the SUMO4/IDDM5 region in affected sib-pair families with type I diabetes
Genes & Immunity (2009)
-
SUMO4 M55V polymorphism affects susceptibility to type I diabetes in HLA DR3- and DR4-positive Swedish patients
Genes & Immunity (2007)
-
Genetic epidemiology of type 1 diabetes
Current Diabetes Reports (2006)